Remibrutinib beneficial for urticaria after H1-antihistamine treatment
For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, ...
2 Minute Medicine1d
Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines
In this randomized controlled trial, among patients with chronic spontaneous urticaria who continue to have symptoms while on ...
Medscape1d
Key Highlights on Urticaria From AAD 2025: Advances in CSU Treatment and Management
Dr Adam Friedman recounts how AAD 2025 highlighted advancements in chronic spontaneous urticaria management, with discussion on new therapies and the role of diet.
Rolling Out5d
Hives or rash? 4 things causing it on Black skin
Skin reactions can be alarming, especially when they appear suddenly. Many people struggle to tell the difference between ...
Healio4d
Itch, urticaria activity improve with dupilumab after refractory antihistamine treatment
Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch and urticaria activity with dupilumab, according to a poster presented here.
Killer sting in Kerala: Wasps and bees cause fatal attacks as casualties rise
The state government has begun paying compensation for wasp and bee sting casualties but has not taken any steps to destroy ...
Verywell Health on MSN4d
Xyzal vs. Zyrtec: How Do They Compare for Allergies?
Xyzal (levocetirizine) and Zyrtec (cetirizine) are over-the-counter (OTC) allergy medications. Learn about their key ...
Rheumatology Advisor1d
FDA Drug Approval Decisions Expected in April 2025
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.